The anti-SLAMF7 elotuzumab enhances ADCC activity with Th1-like γδT cells towards osteoclasts and myeloma cells

The anti-SLAMF7 elotuzumab enhances ADCC activity with Th1-like γδT cells towards osteoclasts and myeloma cells

Bibliographic Details
Main Authors: Hirofumi Tenshin, Takeshi Harada, Yusuke Inoue, Jumpei Teramachi, Masahiro Hiasa, Asuka Oda, Kotaro Tanimoto, So Shimizu, Yoshiki Higa, Masahiro Oura, Kimiko Sogabe, Tomoyo Hara, Tomoko Maruhashi, Itsuro Endo, Toshio Matsumoto, Eiji Tanaka, Masahiro Abe
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:Bone Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2352187221001571
id doaj-88af140f404d42a6a09bf171901546ab
record_format Article
spelling doaj-88af140f404d42a6a09bf171901546ab2021-05-02T05:55:31ZengElsevierBone Reports2352-18722021-04-0114100902The anti-SLAMF7 elotuzumab enhances ADCC activity with Th1-like γδT cells towards osteoclasts and myeloma cellsHirofumi Tenshin0Takeshi Harada1Yusuke Inoue2Jumpei Teramachi3Masahiro Hiasa4Asuka Oda5Kotaro Tanimoto6So Shimizu7Yoshiki Higa8Masahiro Oura9Kimiko Sogabe10Tomoyo Hara11Tomoko Maruhashi12Itsuro Endo13Toshio Matsumoto14Eiji Tanaka15Masahiro Abe16Tokushima University, Department of Orthodontics and Dentofacial Orthopedics, Tokushima-Shi, Japan; Corresponding author.Tokushima University, Department of Hematology- Endocrinology and Metabolism, Tokushima-Shi, JapanTokushima University, Department of Hematology- Endocrinology and Metabolism, Tokushima-Shi, JapanOkayama University, Department of Oral Function and Anatomy, Okayama-shi, JapanTokushima University, Department of Orthodontics and Dentofacial Orthopedics, Tokushima-Shi, JapanTokushima University, Department of Hematology- Endocrinology and Metabolism, Tokushima-Shi, JapanTokushima University, Department of Orthodontics and Dentofacial Orthopedics, Tokushima-Shi, JapanTokushima University, Department of Orthodontics and Dentofacial Orthopedics, Tokushima-Shi, JapanTokushima University, Department of Orthodontics and Dentofacial Orthopedics, Tokushima-Shi, JapanTokushima University, Department of Hematology- Endocrinology and Metabolism, Tokushima-Shi, JapanTokushima University, Department of Hematology- Endocrinology and Metabolism, Tokushima-Shi, JapanTokushima University, Department of Hematology- Endocrinology and Metabolism, Tokushima-Shi, JapanTokushima University, Department of Hematology- Endocrinology and Metabolism, Tokushima-Shi, JapanTokushima University, Department of Chronomedicine, Tokushima-shi, JapanTokushima University, Fujii Memorial Institute of Medical Sciences, Tokushima-shi, JapanTokushima University, Department of Orthodontics and Dentofacial Orthopedics, Tokushima-Shi, JapanTokushima University, Department of Hematology- Endocrinology and Metabolism, Tokushima-Shi, Japanhttp://www.sciencedirect.com/science/article/pii/S2352187221001571
collection DOAJ
language English
format Article
sources DOAJ
author Hirofumi Tenshin
Takeshi Harada
Yusuke Inoue
Jumpei Teramachi
Masahiro Hiasa
Asuka Oda
Kotaro Tanimoto
So Shimizu
Yoshiki Higa
Masahiro Oura
Kimiko Sogabe
Tomoyo Hara
Tomoko Maruhashi
Itsuro Endo
Toshio Matsumoto
Eiji Tanaka
Masahiro Abe
spellingShingle Hirofumi Tenshin
Takeshi Harada
Yusuke Inoue
Jumpei Teramachi
Masahiro Hiasa
Asuka Oda
Kotaro Tanimoto
So Shimizu
Yoshiki Higa
Masahiro Oura
Kimiko Sogabe
Tomoyo Hara
Tomoko Maruhashi
Itsuro Endo
Toshio Matsumoto
Eiji Tanaka
Masahiro Abe
The anti-SLAMF7 elotuzumab enhances ADCC activity with Th1-like γδT cells towards osteoclasts and myeloma cells
Bone Reports
author_facet Hirofumi Tenshin
Takeshi Harada
Yusuke Inoue
Jumpei Teramachi
Masahiro Hiasa
Asuka Oda
Kotaro Tanimoto
So Shimizu
Yoshiki Higa
Masahiro Oura
Kimiko Sogabe
Tomoyo Hara
Tomoko Maruhashi
Itsuro Endo
Toshio Matsumoto
Eiji Tanaka
Masahiro Abe
author_sort Hirofumi Tenshin
title The anti-SLAMF7 elotuzumab enhances ADCC activity with Th1-like γδT cells towards osteoclasts and myeloma cells
title_short The anti-SLAMF7 elotuzumab enhances ADCC activity with Th1-like γδT cells towards osteoclasts and myeloma cells
title_full The anti-SLAMF7 elotuzumab enhances ADCC activity with Th1-like γδT cells towards osteoclasts and myeloma cells
title_fullStr The anti-SLAMF7 elotuzumab enhances ADCC activity with Th1-like γδT cells towards osteoclasts and myeloma cells
title_full_unstemmed The anti-SLAMF7 elotuzumab enhances ADCC activity with Th1-like γδT cells towards osteoclasts and myeloma cells
title_sort anti-slamf7 elotuzumab enhances adcc activity with th1-like γδt cells towards osteoclasts and myeloma cells
publisher Elsevier
series Bone Reports
issn 2352-1872
publishDate 2021-04-01
url http://www.sciencedirect.com/science/article/pii/S2352187221001571
work_keys_str_mv AT hirofumitenshin theantislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT takeshiharada theantislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT yusukeinoue theantislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT jumpeiteramachi theantislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT masahirohiasa theantislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT asukaoda theantislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT kotarotanimoto theantislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT soshimizu theantislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT yoshikihiga theantislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT masahirooura theantislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT kimikosogabe theantislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT tomoyohara theantislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT tomokomaruhashi theantislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT itsuroendo theantislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT toshiomatsumoto theantislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT eijitanaka theantislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT masahiroabe theantislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT hirofumitenshin antislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT takeshiharada antislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT yusukeinoue antislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT jumpeiteramachi antislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT masahirohiasa antislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT asukaoda antislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT kotarotanimoto antislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT soshimizu antislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT yoshikihiga antislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT masahirooura antislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT kimikosogabe antislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT tomoyohara antislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT tomokomaruhashi antislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT itsuroendo antislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT toshiomatsumoto antislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT eijitanaka antislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
AT masahiroabe antislamf7elotuzumabenhancesadccactivitywithth1likegdtcellstowardsosteoclastsandmyelomacells
_version_ 1721494657031995392

Similar Items